is hers still selling semaglutide Everything You Need to Know About Weight Loss Hims & Hers Super Bowl

They operate on staggering 80% to 85% gross margins to recoup billions in R&D and secure dominant market positions before their patents expire

Format: Research Peptide

As we were enjoying the positive human infusion data and anticipating a major effort to design both protease resistant GLP-1 analogues and an inhibitor of the responsible protease as new diabetes therapies, I was shocked when told that senior Pfizer leadership had concluded that there would never be another injectable therapy for diabetes other than insulin. To view or add a comment, sign in More Relevant Posts FDA July 2026 New Drug Therapy Approval A New Step Forward in Kidney Disease Treatment

Employers that offer GLP1 coverage through a lifestyle or wellness program, should review it for compliance with HIPAAs healthcontingent wellness rules and the ADAs standards for programs involving medical questions or exams

Pause therapy one week before and after any surgery